BillionaireNet
Daidi
F
Rank #1412
CHINAFashion & RetailSkincare

Fan Daidi

Net Worth
$2.842B
-1.35% (24h)
Fan Daidi, a pioneering scientist and businesswoman, is a prominent figure in China's skincare industry. Born in 1966, she earned a Ph.D. in biochemical engineering and has become renowned for her work in recombinant collagen, the foundation of her skincare empire. With a current net worth of $3.0 billion, Fan is the co-founder of Giant Biogene Holding, a leading collagen-based skincare product supplier, and also serves as the vice president of Northwest University in Xi'an, China, demonstrating her commitment to both business and academia. Her career is marked by significant achievements in the field of biochemistry and business leadership, making her one of the wealthiest self-made women in China.

The Full Dossier

Early Life and Education

Fan Daidi was born in 1966 in a rural village in Shaanxi Province, China. She pursued a strong academic path, earning bachelor's and master's degrees in chemistry from Northwest University in the 1980s. She furthered her education with a Ph.D. in biochemical engineering from East China University of Science and Technology in Shanghai in 1994, becoming the first woman in China to earn a doctorate in that field.

Rise to Success

After completing her doctorate, Fan returned to Northwest University to teach and conduct research. Her focus shifted to recombinant collagen synthesis, which became the cornerstone of her future business endeavors. In 2000, she successfully developed recombinant collagen technology and, with her husband Yan Jianya, founded Giant Biogene. The company became a leader in collagen-based skincare products. In 2022, Giant Biogene was listed on the Hong Kong Stock Exchange, solidifying Fan's status as a billionaire. In April 2024, Fan was appointed as the vice-president of Northwest University, indicating her continued influence in academia alongside her business ventures.

Key Business Strategies

Fan Daidi's success is attributed to her ability to commercialize her scientific innovations. Her core business strategy revolved around the development and marketing of high-quality, recombinant collagen-based skincare products. This approach allowed her to secure a large share in the Chinese skincare market. Giant Biogene's products include skincare products, medical dressings, and popular beauty masks like Kefumei and Kefuxin. The company's focus on R&D, with 86 patents and pending patents, has been central to its growth.

Philanthropy

Giant Biogene has been involved in healthcare in China, donating money and equipment totaling 4.67 million yuan. Fan also treats educating students as her priority.

Career Timeline

2024

Vice President of Northwest University

Appointed Vice President of Northwest University in Xi'an, China.

2023

Resigned as Executive Director of Giant Biogene

Stepped down from her executive director role.

2022

Giant Biogene IPO

Giant Biogene listed on the Hong Kong Stock Exchange.

2000

Founded Giant Biogene

Co-founded Giant Biogene with her husband, Yan Jianya, and developed a high-density fermentation technology to produce human-like collagen.

1998

Started Research on Recombinant Collagen

Began research in her lab on the synthesis of recombinant collagen, utilizing genetic engineering.

1994

Earned a PhD in Biochemical Engineering

Graduated from East China University of Science and Technology, becoming the first woman in China with a PhD in Biochemical Engineering.

Philanthropic Impact

Healthcare$0.7B

Healthcare Donations

Giant Biogene has donated money and equipment totaling 4.67 million yuan.

Wealth Trajectory